Medicine
Divalproex 125 mg capsule
Divalproex 125 mg capsule is a generic prescription medicine for oral use, made by 9 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Divalproex
- Brand
- Sold under the generic name
- Strength
- 125 mg
- Dosage form
- Capsule
- Route
- Oral
- Packs
- 100 capsules, 1000 capsules, 10 blister pack and 23 more
- Manufacturers
- Zydus LifesciencesIndiaLifestar PharmaIndiaAjanta PharmaIndiaVangard LabsRemedyrepackAmerican Health PackagingFirst Nation GroupAtlantic BiologicalsCardinal Health
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N03AG01 Valproic acid
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 23 January 2009
- Identifiers
- RxCUI 1099596DailyMed set ID 699a9722-27bd-4e90-819b-d4ecb99466c8, ab8616a5-ea72-4df7-b095-54ea19ef6fba, 388fd4bc-f12f-4e55-a1e7-72aa585519fa +8NDC 17856-0109, 70518-1749, 0615-8237 +8Application ANDA078919, ANDA078979, ANDA217358 +1
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 capsule, coated pellets in 1 bottle | 65841-639-01 | Zydus LifesciencesIndia | 27 January 2009 |
| 1000 capsule, coated pellets in 1 bottle | 65841-639-10 | Zydus LifesciencesIndia | 27 January 2009 |
| 10 blister pack in 1 carton / 10 capsule, coated pellets in 1 blister pack | 65841-639-30 | Zydus LifesciencesIndia | 27 January 2009 |
| 100 capsule, coated pellets in 1 bottle | 68382-106-01 | Zydus LifesciencesIndia | 27 January 2009 |
| 1000 capsule, coated pellets in 1 bottle | 68382-106-10 | Zydus LifesciencesIndia | 27 January 2009 |
| 100 blister pack in 1 carton / 1 capsule, coated pellets in 1 blister pack | 68382-106-77 | Zydus LifesciencesIndia | 27 January 2009 |
| 100 capsule, coated pellets in 1 bottle | 27241-115-01 | Ajanta PharmaIndia | 15 May 2020 |
| 500 capsule, coated pellets in 1 bottle | 27241-115-05 | Ajanta PharmaIndia | 15 May 2020 |
| 1000 capsule, coated pellets in 1 bottle | 27241-115-10 | Ajanta PharmaIndia | 15 May 2020 |
| 100 capsule, coated pellets in 1 bottle | 70756-447-11 | Lifestar PharmaIndia | 12 August 2025 |
| 1000 capsule, coated pellets in 1 bottle | 70756-447-12 | Lifestar PharmaIndia | 12 August 2025 |
| 30 capsule, coated pellets in 1 bottle | 70756-447-30 | Lifestar PharmaIndia | 12 August 2025 |
| 500 capsule, coated pellets in 1 bottle | 70756-447-51 | Lifestar PharmaIndia | 12 August 2025 |
| 100 capsule, coated pellets in 1 bottle | 81469-492-01 | First Nation Group | 10 November 2025 |
| 1000 capsule, coated pellets in 1 bottle | 81469-492-10 | First Nation Group | 10 November 2025 |
| 100 pouch in 1 box / 1 capsule, coated pellets in 1 pouch | 70518-1749-1 | Remedyrepack | 17 December 2018 |
| 100 pouch in 1 box / 1 capsule, coated pellets in 1 pouch | 70518-3457-2 | Remedyrepack | 1 August 2023 |
| 30 capsule, coated pellets in 1 blister pack | 70518-3457-4 | Remedyrepack | 18 February 2026 |
| 100 blister pack in 1 box, unit-dose / 1 capsule, coated pellets in 1 blister pack | 68084-313-01 | American Health Packaging | 18 March 2009 |
| 50 blister pack in 1 carton / 1 capsule, coated pellets in 1 blister pack | 68084-313-65 | American Health Packaging | 26 June 2024 |
| 100 pouch in 1 box / 1 capsule, coated pellets in 1 pouch | 17856-0109-1 | Atlantic Biologicals | 28 January 2021 |
| 10 blister pack in 1 bag / 1 capsule, coated pellets in 1 blister pack | 55154-4759-0 | Cardinal Health | 18 March 2009 |
| 15 capsule in 1 blister pack | 0615-8237-05 | Vangard Labs | 27 August 2018 |
| 28 capsule in 1 blister pack | 0615-8237-28 | Vangard Labs | 19 April 2024 |
| 6 blister pack in 1 box, unit-dose / 5 capsule in 1 blister pack | 0615-8237-30 | Vangard Labs | 27 August 2018 |
| 30 capsule in 1 blister pack | 0615-8237-39 | Vangard Labs | 27 August 2018 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 10 March 1983 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Divalproex 125 mg capsule.
Other strengths and forms of Divalproex
Clinical summary
Divalproex is an anti-epileptic agent indicated for treatment of manic episodes associated with bipolar disorder, among other approved uses. It is available as delayed-release tablets, extended-release tablets and capsules for oral use. MedsAcross supplies Divalproex for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about DivalproexFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Depakote prescribing information (AbbVie) · U.S. National Library of Medicine, DailyMed
Need Divalproex 125 mg capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.